Hemodialysis - Different Aspects 2011
DOI: 10.5772/22735
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Iron Metabolism and Hepcidin Release by HFE Mutations in Chronic Hemodialysis Patients: Pathophysiological and Therapeutic Implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
8
1

Year Published

2013
2013
2017
2017

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(10 citation statements)
references
References 151 publications
1
8
1
Order By: Relevance
“…We previously reported that in CHD patients common HFE mutations that alter hepatic iron sensing [13] were associated with lower hepcidin levels relatively to iron stores [6,14], achievement of target Hb levels for lower doses of iron, and with reduced mortality due to sepsis and cardiovascular disease, previously linked to more intense iron supplementation [15-18]. These initial results are in line with the hypothesis that inhibition of hepcidin in CHD may improve anemia control, and even survival in CHD patients [2,3,19,20]. …”
Section: Introductionmentioning
confidence: 75%
See 4 more Smart Citations
“…We previously reported that in CHD patients common HFE mutations that alter hepatic iron sensing [13] were associated with lower hepcidin levels relatively to iron stores [6,14], achievement of target Hb levels for lower doses of iron, and with reduced mortality due to sepsis and cardiovascular disease, previously linked to more intense iron supplementation [15-18]. These initial results are in line with the hypothesis that inhibition of hepcidin in CHD may improve anemia control, and even survival in CHD patients [2,3,19,20]. …”
Section: Introductionmentioning
confidence: 75%
“…In CHD patients, it is usually difficult to control anemia because of a complex derangement of iron metabolism, which is due to chronic inflammation, blood losses, and concomitant Epo administration [2]. Increased serum levels of hepcidin, the hepatic hormone regulating iron metabolism, have been suggested to contribute to the functional iron deficiency that limit erythropoiesis in CHD [2,3,31].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations